Key result
Hybrid cardiovascular procedures integrate percutaneous and open surgery for high-risk patients with complex structural challenges.
Hybrid cardiovascular procedures represent a growing and collaborative approach integrating percutaneous and surgical treatments for high-risk patients.
May support hybrid strategies in select high-risk cases; leaves open prospective trials to guide selection and outcomes.
Cardiovascular consultants are increasingly faced with patients presenting with multiple comorbidities or structural challenges, who are in need for anatomical corrections. In such patients, hybrid cardiovascular procedures often allow for collaborative therapies that integrate the strengths of percutaneous and traditional open surgical treatments, to provide an overarching treatment that cannot be provided by either approach in isolation. While the concept of hybrid cardiovascular therapy is not new, it has seen a resurgence in recent years, with the developement of new devices and approaches. Areas of particular growth within hybrid cardiovascular care include hybrid myocardial revascularization, hybrid therapies for valvular and structural heart diseases and hybrid procedures for aortic diseases. Future growth in this field is inevitable and represents an exciting frontier in cardiovascular medicine.
No takes yet. Share an insight, caveat, or question.
Muhammad et al. (2011) conducted a review in Cardiovascular diseases with multiple comorbidities or structural challenges. Hybrid cardiovascular procedures was evaluated. Hybrid cardiovascular procedures integrate percutaneous and open surgical treatments to provide overarching therapy for high-risk patients with complex structural challenges.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: